They provided scenarios of tumor reduction or elimination by decreasing the secretion of CSF-1, EGF, the density of macrophages, chemotaxis sensitivity, and increasing the degradation of CSF-1 or EGF. The gene discussed is CSF1; the disease is neoplasm.